|
|
|
|
|
|
by BioGeek
5898 days ago
|
|
|
The health department of the stae of New York considers 23andMe’s genome scan to be a medical test that must be approved by regulators and ordered by a doctor. A competing company, Navigenics, successfully applied to have its test licensed in New York. It has essentially put aside marketing to consumers, aiming instead at doctors. It is also courting corporations that might use the test as part of their employee wellness programs. http://www.nytimes.com/2010/03/20/business/20consumergenebar... |
|
|